Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin

Journal of the American Academy of Dermatology

Volumn 45, Issue 2, 2001, Pages 196-207

  Strauss, John S ^a   Leyden, James J ^b   Lucky, Anne W ^c   Lookingbill, Donald P ^d   Drake, Lynn A ^e   Hanifin, Jon M ^f   Lowe, Nicholas J ^g   Jones, Terry M ^h   Stewart, Daniel M ⁱ   Jarratt, Michael T ^j   Katz, Irving ^k   Pariser, David M ^l   Pariser, Robert J ^l   Tschen, Eduardo ^m   Chalker, Dan K ⁿ   Rafal, Elyse S ^o   Savin, Ronald P ^p   Roth, Harry L ^q   Chang, Lawrence K ^a   Baginski, David J ^a   Kempers, Steven ^k   McLane, John ^r   Eberhardt, Douglas ^r   Leach, Eileen E ^r   Bryce, Graeme ^r   Hong, Joseph ^r   more..

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c Dermatology Research Associates   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g Clinical Research Specialists   (United States)

^h J and S Studies   (United States)

ⁱ Midwest Cutaneous Research   (United States)

^j DermResearch Inc   (United States)

^k Minnesota Clinical Study Center   (United States)

^l EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^m Academic Dermatology Associates   (United States)

ⁿ DK Clinical Research   (United States)

^o DermResearch Center of New York   (United States)

^p Savin Dermatology Center   (United States)

^q Harry L Roth Professional Corporation   (United States)

^r HOFFMANN LA ROCHE INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; ADULT; ARTICLE; BIOEQUIVALENCE; CHEILITIS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SAFETY; EPISTAXIS; ERYTHEMA; EYE IRRITATION; FEMALE; FOOD DRUG INTERACTION; HEADACHE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN DEFECT; XEROPHTHALMIA;

EID: 17844374318     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.115966     Document Type: Article

References (17)

1. Medical complications of isotretinoin
2. Adverse effects of retinoids
3. Adverse reactions to oral retinoids: An update
4. Isotretinoin therapy for acne: Results of a multicenter dose-response study
5. Long-term safety of isotretinoin as a treatment for acne vulgaris
6. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne
7. Consensus conference. Treatment of hypertriglyceridemia
8. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne
9. An observational study of isotretinoin recipients treated for acne in a health maintenance organization
10. Optimal resources for primary prevention of atherosclerotic disease
11. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
12. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction
13. Epidemiology of headache in a general population - A prevalence study
14. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis
15. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
16. The psychological and emotional impact of acne and the effect of treatment with isotretinoin